🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-arm, open-label, single-center prospective phase II study ...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2018-01-24
Trial ID
NCT03485027
Treatments Being Tested
This is a multicenter, open-label phase Ib/IIa clinical study conducted in ...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-03-25
Trial ID
NCT07056777
Treatments Being Tested
This phase Ib trial studies the side effects and best dose of selinexor whe...
Status
Terminated
Location
MD Anderson in The Woodlands
Start Date
2015-06-26
Trial ID
NCT02419495
The purpose of this study was to determine the activity of two doses of rob...
Status
Completed
Location
Multiple Locations
Start Date
2007-11-21
Trial ID
NCT00551213
Treatments Being Tested
For locally advanced rectal cancer, the initial goal of neoadjuvant chemora...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-11-01
Trial ID
NCT06099951
Treatments Being Tested
Ampullary adenocarcinoma (AAC) is a rare gastrointestinal cancer with varyi...
Status
Recruiting
Location
Fondazione Poliambulanza
Start Date
2023-07-01
Trial ID
NCT06068023
Treatments Being Tested
This is an open-label, single-arm, single-center phase II clinical study, a...
Status
Not Yet Recruiting
Location
Harbin Medical University Cancer Hosptital
Start Date
2026-02
Trial ID
NCT07229846
The objective is to compare the efficacy and safety of CAPOXIRI+BEV therapy...
Status
Unknown
Location
Ac Medical Inc.
Start Date
2019-10-11
Trial ID
NCT04097444
Treatments Being Tested
This study is being done to evaluate the safety and efficacy of adding NIS7...
Status
Terminated
Location
Brigham and Women's Hospital
Start Date
2023-01-06
Trial ID
NCT05546411
Treatments Being Tested
This phase II trial compares the effect of irinotecan versus oxaliplatin af...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2022-12-08
Trial ID
NCT05610163